C3 synthesis and CRs expression during differentiation of a murine stem cell line.

[1]  W. Prodinger,et al.  C3 molecules internalize and enhance the growth of Lewis lung carcinoma cells. , 1999, Immunobiology.

[2]  A. Zicari,et al.  The hemopoietic progenitor 32DCl3(G) cells synthesize C3 molecules and acquire C3b acceptor sites upon differentiation or neoplastic transformation. , 1993, Journal of immunology.

[3]  G. Soma,et al.  Expression of transcripts of complement components and their receptors during differentiation of embryonal carcinoma cell lines. , 1992, Biochemical and biophysical research communications.

[4]  M. Walport,et al.  Biosynthesis and secretion of complement component (C3) by activated human polymorphonuclear leukocytes. , 1992, Journal of immunology.

[5]  T. Tachibana,et al.  Secretion and function of the third component of complement (C3) by murine leukocytes. , 1992, International immunology.

[6]  Y. Ishimi,et al.  Transcriptional regulation of the production of the third component of complement (C3) by 1 alpha,25-dihydroxyvitamin D3 in mouse marrow-derived stromal cells (ST2) and primary osteoblastic cells. , 1991, Endocrinology.

[7]  G. Füst,et al.  The role of C3 in the immune response. , 1991, Immunology today.

[8]  T. Okuda.  Murine polymorphonuclear leukocytes synthesize and secrete the third component and factor B of complement. , 1991, International immunology.

[9]  B. Nilsson,et al.  C3d-mediated negative and positive signals on the proliferation of human B cells separated from blood. , 1990, Immunology letters.

[10]  G. Rovera,et al.  Alteration of the Program of Terminal Differentiation Caused by Oncogenes in the Hemopoietic Progenitor Cell Line 32D C13 (G) a , 1989, Annals of the New York Academy of Sciences.

[11]  John D Lambris,et al.  C3 synthetic peptides support growth of human CR2-positive lymphoblastoid B cells. , 1989, Journal of immunology.

[12]  E. Reddy,et al.  Alteration of growth and differentiation factors response by Kirsten and Harvey sarcoma viruses in the IL-3-dependent murine hematopoietic cell line 32D C13(G). , 1989, Oncogene.

[13]  G. Soma,et al.  Endogenous and exogenous TNF therapy (EET therapy): conceptual and experimental grounds. , 1988, Annales de l'Institut Pasteur. Immunology.

[14]  H. Colten,et al.  Cachectin/tumor necrosis factor regulates hepatic acute-phase gene expression. , 1986, The Journal of clinical investigation.

[15]  I. G. Young,et al.  Constitutive synthesis of interleukin-3 by leukaemia cell line WEHI-3B is due to retroviral insertion near the gene , 1985, Nature.

[16]  T. Egwang,et al.  The role of complement in the induction and regulation of immune responses. , 1984, Immunology.

[17]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[18]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[19]  J. Volanakis.  Transcriptional regulation of complement genes. , 1995, Annual review of immunology.